![Dr. Sergio Vañó on Twitter: "Treatment of male #AndrogeneticAlopecia with oral dutasteride and low dose oral minoxidil. 💊 💊 Early response after 4 months. ➡️ No adverse effects were detected! #tricoHRC #tricologiaGPJ # Dr. Sergio Vañó on Twitter: "Treatment of male #AndrogeneticAlopecia with oral dutasteride and low dose oral minoxidil. 💊 💊 Early response after 4 months. ➡️ No adverse effects were detected! #tricoHRC #tricologiaGPJ #](https://pbs.twimg.com/media/D8I1Ca2WsAAcLNV.jpg)
Dr. Sergio Vañó on Twitter: "Treatment of male #AndrogeneticAlopecia with oral dutasteride and low dose oral minoxidil. 💊 💊 Early response after 4 months. ➡️ No adverse effects were detected! #tricoHRC #tricologiaGPJ #
![Combination treatment of extensive and recalcitrant alopecia areata with oral and topical steroids with topical minoxidil: An open-label study of efficacy and safety in pediatric patients Combination treatment of extensive and recalcitrant alopecia areata with oral and topical steroids with topical minoxidil: An open-label study of efficacy and safety in pediatric patients](https://ijpd.in/articles/2016/17/3/images/IndianJPaediatrDermatol_2016_17_3_173_179484_f1.jpg)
Combination treatment of extensive and recalcitrant alopecia areata with oral and topical steroids with topical minoxidil: An open-label study of efficacy and safety in pediatric patients
![PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”](https://i1.rgstatic.net/publication/335764203_Reply_to_Very-low-dose_oral_minoxidil_in_male_androgenetic_alopecia_A_study_with_quantitative_trichoscopic_documentation/links/5e6e6acb92851c6ba706407c/largepreview.png)
PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”
![Surgical & Cosmetic Dermatology | Adjuvant oral minoxidil for the treatment of alopecia areata refractory to Janus kinase inhibitors Surgical & Cosmetic Dermatology | Adjuvant oral minoxidil for the treatment of alopecia areata refractory to Janus kinase inhibitors](http://www.surgicalcosmetic.org.br/content/imagebank/figuras/v12n1a11-fig02.jpg)
Surgical & Cosmetic Dermatology | Adjuvant oral minoxidil for the treatment of alopecia areata refractory to Janus kinase inhibitors
![Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation - Jha - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation - Jha - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/999a788e-6327-4711-b67b-17e045253acb/jocd14049-fig-0005-m.jpg)
Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation - Jha - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library
![Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls - Journal of the American Academy of Dermatology Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/1c9fb373-3c6e-4f19-a371-931dcb39f50e/gr1.jpg)
Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls - Journal of the American Academy of Dermatology
![Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” - Journal of the American Academy of Dermatology Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c8586823-e118-4464-a9b3-ab144819fe57/gr1_lrg.jpg)